Welcome to the
European Biotechnology Network!

The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe.

The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.

Read more about our activities here.


The European Biotechnology Network has been making an assessment of the potential impact of Brexit on the scientific community in Europe and completed a survey for actors in the science community in the UK and also across the rest of the EU.
From recent UK government statements, Brexit will be completed by April 2019. With the current position on freedom of movement, there is likely to be significantly reduced access to H2020 and future Framework programmes, plus limited access to the single market on a tariff-free basis. From this position, it is also likely that the UK will require domestic regulatory agencies and may follow divergent regulatory pathways from future EU requirements. Until that time, the UK is likely to have existing levels of access to EU structures and funds, unless specific changes are made.
We collected survey responses from members and the wider community and will generate a report that reflects how UK scientists think they will be impacted and how the rest of the EU now views the UK as a science and business centre. We received an excellent response to the questionnaire, with over 350 respondents. EBN would like to thank members and the wider scientific community for their efforts.

Featured Events

Our Corporate Members are


All events

Membership - Join the Network!

Individual Membership for natural persons is free, while Corporate Membership, for companies, institutions and research groups start from €500 p.a.
Click here to apply for network membership!


European Biotechnology Network AISBL

Rue de la Science 14b
1040 Brussels, Belgium

Tel: +32 27 33 72 37

Funding Hub Strategic Partnership

European Biopharmaceutical Enterprises